{"id":"https://openalex.org/W4403520002","doi":"https://doi.org/10.1158/2326-6074.tumimm24-a028","title":"Abstract A028: Cycling T regulatory cells architect an immune escape hub during in situ to invasive breast carcinoma transition","display_name":"Abstract A028: Cycling T regulatory cells architect an immune escape hub during in situ to invasive breast carcinoma transition","publication_year":2024,"publication_date":"2024-10-18","ids":{"openalex":"https://openalex.org/W4403520002","doi":"https://doi.org/10.1158/2326-6074.tumimm24-a028"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6074.tumimm24-a028","doi":"https://doi.org/10.1158/2326-6074.tumimm24-a028","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm24-a028","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028852097","display_name":"Triet Minh Bui","orcid":"https://orcid.org/0000-0002-1092-9820","observed_orcids":["https://orcid.org/0000-0002-1092-9820"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Triet Minh Bui","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA 1","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ernesto A Rojas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ernesto A Rojas","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA 1","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034098346","display_name":"Pierre Foidart","orcid":"https://orcid.org/0000-0003-4198-271X","observed_orcids":["https://orcid.org/0000-0003-4198-271X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pierre Foidart","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA 1","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073085049","display_name":"Zheqi Li","orcid":"https://orcid.org/0000-0003-1213-640X","observed_orcids":["https://orcid.org/0000-0003-1213-640X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zheqi Vaciry Li","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA 1","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076711921","display_name":"Pengze Yan","orcid":"https://orcid.org/0000-0001-8142-0944","observed_orcids":["https://orcid.org/0000-0001-8142-0944"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pengze Yan","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA 1","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jun Nishida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Nishida","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA 1","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044981994","display_name":"Robert B. West","orcid":"https://orcid.org/0000-0002-8330-8283","observed_orcids":["https://orcid.org/0000-0002-8330-8283"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert West","raw_affiliation_strings":["Stanford University School of Medicine, Stanford, CA 2"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University School of Medicine, Stanford, CA 2","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103530129","display_name":"Shelley E. Hwang","orcid":"https://orcid.org/0000-0002-8571-1148","observed_orcids":["https://orcid.org/0000-0002-8571-1148"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shelley Hwang","raw_affiliation_strings":["Duke University School of Medicine, Durham, NC. 3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University School of Medicine, Durham, NC. 3","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081194463","display_name":"Simona Cristea","orcid":"https://orcid.org/0009-0003-1276-186X","observed_orcids":["https://orcid.org/0009-0003-1276-186X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simona Cristea","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA 1","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014395742","display_name":"Korn\u00e9lia Poly\u00e1k","orcid":"https://orcid.org/0000-0002-5964-0382","observed_orcids":["https://orcid.org/0000-0002-5964-0382"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kornelia Polyak","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA 1","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"10_Supplement","first_page":"A028","last_page":"A028"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8330000042915344,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8330000042915344,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.13770000636577606,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ductal-carcinoma-in-situ","display_name":"ductal carcinoma in situ","score":0.8550000190734863},{"id":"https://openalex.org/keywords/invasive-breast-cancer","display_name":"invasive breast cancer","score":0.9629999995231628},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.8270000219345093},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.8500000238418579},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8289999961853027},{"id":"https://openalex.org/keywords/ox40-agonist","display_name":"OX40 agonist","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cd8-t-cell-infiltration","display_name":"CD8+ T cell infiltration","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.9679999947547913},{"id":"https://openalex.org/keywords/treg-expansion","display_name":"Treg expansion","score":0.6420000195503235},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.6000000238418579},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C541528975","wikidata":"https://www.wikidata.org/wiki/Q53121","display_name":"Cycling","level":2,"score":0.5804140567779541},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5710313320159912},{"id":"https://openalex.org/C2777822432","wikidata":"https://www.wikidata.org/wiki/Q216681","display_name":"In situ","level":2,"score":0.5504103302955627},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4905332922935486},{"id":"https://openalex.org/C2991678113","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immune modulation","level":3,"score":0.46108242869377136},{"id":"https://openalex.org/C2777661416","wikidata":"https://www.wikidata.org/wiki/Q1035645","display_name":"Carcinoma in situ","level":3,"score":0.44029417634010315},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4347652494907379},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38946083188056946},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38276493549346924},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.34537214040756226},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32147854566574097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28849589824676514},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.20134446024894714},{"id":"https://openalex.org/C205649164","wikidata":"https://www.wikidata.org/wiki/Q1071","display_name":"Geography","level":0,"score":0.09800723195075989},{"id":"https://openalex.org/C97137747","wikidata":"https://www.wikidata.org/wiki/Q38112","display_name":"Forestry","level":1,"score":0.07892158627510071},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6074.tumimm24-a028","doi":"https://doi.org/10.1158/2326-6074.tumimm24-a028","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm24-a028","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6000000238418579,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2396534229","https://openalex.org/W2135440372","https://openalex.org/W2922415454","https://openalex.org/W4396712140","https://openalex.org/W1965853983","https://openalex.org/W4391375468","https://openalex.org/W1996037090","https://openalex.org/W2183888961","https://openalex.org/W2056763681","https://openalex.org/W4362554100"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"tumor":[2,7,137],"immune":[3,33,90,205,222,258],"microenvironment":[4],"shapes":[5],"breast":[6,20,57,266],"evolution.":[8],"We":[9,59,102],"previously":[10],"described":[11],"the":[12,38,66,85,89,143,167,219,273],"ductal":[13],"carcinoma":[14,21,267],"in":[15,62,98,111,126,175,182,225,262,277],"situ":[16,263],"(DCIS)":[17],"to":[18,113,193,264],"invasive":[19,94,208,265],"(IBC)":[22],"transition":[23,268],"as":[24,65,84,201],"an":[25,257],"evolutionary":[26],"bottleneck":[27],"and":[28,41,46,50,72,74,117,135,150,178,184,210,282],"a":[29,76,148],"key":[30,202],"step":[31],"of":[32,44,88,166,191,204,221,272],"escape.":[34],"Here,":[35],"we":[36],"dissected":[37],"cellular":[39],"composition":[40],"spatial":[42],"topology":[43],"DCIS":[45,71,177],"IBC":[47,73],"patient":[48,168,180],"samples":[49],"rat":[51],"tumors":[52],"that":[53,104,120,158,171,185,212],"faithfully":[54],"recapitulate":[55],"human":[56],"cancer.":[58],"identified":[60],"differences":[61],"T":[63,80,132,253],"cells":[64,255],"main":[67],"distinguishing":[68],"feature":[69],"between":[70],"discovered":[75],"novel":[77],"cycling":[78],"regulatory":[79,254],"cell":[81,133,145],"population":[82],"(cycTreg)":[83],"primary":[86],"orchestrator":[87],"suppressive":[91],"environment":[92],"during":[93,207,261],"progression,":[95],"especially":[96],"enriched":[97],"triple-negative":[99],"histological":[100],"subtype.":[101],"showed":[103],"cycTregs":[105,172,200],"are":[106],"locally":[107],"expanding":[108],"Treg":[109,149,162],"precursors":[110],"response":[112],"increased":[114,186],"antigen":[115],"presentation,":[116],"further":[118],"demonstrated":[119,170],"modulating":[121],"them":[122],"by":[123],"OX40":[124],"agonist":[125],"combination":[127],"with":[128],"anti-PD-L1":[129],"enhances":[130],"CD8+":[131],"infiltration":[134],"suppresses":[136],"growth.":[138],"Characterizing":[139],"therapeutic":[140],"responses":[141],"at":[142],"single":[144],"level":[146],"revealed":[147],"cancer-associated":[151],"fibroblast":[152],"(CAF)":[153],"crosstalk":[154],"via":[155],"IL33-ST2":[156],"pathway":[157],"is":[159,189,215],"critical":[160],"for":[161,217],"expansion.":[163],"Multimodal":[164],"analysis":[165],"cohorts":[169],"predict":[173],"recurrence":[174],"low-grade":[176],"poor":[179],"outcomes":[181],"IBC,":[183],"CAF-immune-DCIS":[187],"proximity":[188],"prognostic":[190],"progression":[192,209],"IBC.":[194,226],"In":[195],"sum,":[196],"our":[197],"study":[198],"establishes":[199],"drivers":[203],"escape":[206,259],"implies":[211],"their":[213],"targeting":[214],"essential":[216],"enhancing":[218],"efficacy":[220],"checkpoint":[223],"inhibitors":[224],"Citation":[227],"Format:":[228],"Triet":[229],"Minh":[230],"Bui,":[231],"Ernesto":[232],"A":[233],"Rojas,":[234],"Pierre":[235],"Foidart,":[236],"Zheqi":[237],"Vaciry":[238],"Li,":[239],"Pengze":[240],"Yan,":[241],"Jun":[242],"Nishida,":[243],"Robert":[244],"West,":[245],"Shelley":[246],"Hwang,":[247],"Simona":[248],"Cristea,":[249],"Kornelia":[250],"Polyak.":[251],"Cycling":[252],"architect":[256],"hub":[260],"[abstract].":[269],"In:":[270],"Proceedings":[271],"AACR":[274],"Special":[275],"Conference":[276],"Cancer":[278,292],"Research:":[279],"Tumor":[280],"Immunology":[281],"Immunotherapy;":[283],"2024":[284],"Oct":[285],"18-21;":[286],"Boston,":[287],"MA.":[288],"Philadelphia":[289],"(PA):":[290],"AACR;":[291],"Immunol":[293],"Res":[294],"2024;12(10":[295],"Suppl):Abstract":[296],"nr":[297],"A028.":[298]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}